The role of heparan sulfate proteoglycans for tau pathology in vivo
Barbara E Stopschinski, Sandi‐Jo Estill‐Terpack, Sushobhna Batra, Shubhangi Pandey, Jaime Vaquer‐Alicea III, Marc I Diamond · 2025
Read The role of heparan sulfate proteoglycans for tau pathology in vivo by Barbara E Stopschinski, Sandi‐Jo Estill‐Terpack, Sushobhna Batra, Shubhangi Pandey, Jaime Vaquer‐Alicea III, Marc I Diamond (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11710292.txt.
Description
Barbara Stopschinski and co-authors test in a 2025 study whether surface sugar coats gate tau spread in living brains. The prion style model says tau seeds hop between cells to spread disease. Past dish work showed those seeds dock on heparan sulfate chains before entry.
One sugar editing enzyme, NDST1, proved key to that docking in cell models. Gene knockout and rescue runs in human cells anchor the new in vivo push. Heparin tests in mouse neurons and astrocytes extend the uptake checks. A virus delivered silencer targets the enzyme in a tauopathy mouse line. The stepwise plan validates the sugar coat as a drug target candidate.
Catalog record
| CREATOR | Barbara E Stopschinski, Sandi‐Jo Estill‐Terpack, Sushobhna Batra, Shubhangi Pandey, Jaime Vaquer‐Alicea III, Marc I Diamond |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 2 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |